Crossmark

Neurotensin receptor agonist PD149163 modulates the adrenal dysfunction in mice intraperitoneally treated with lipopolysaccharide from Escherichia coli O26:B6

Crossref DOI link: https://doi.org/10.1007/s00580-024-03614-1

Published Online: 2024-10-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tiwari, Asheesh Kumar

Babu, Gyan

Mohanty, Banalata https://orcid.org/0000-0001-8852-6442
License Information

Text and Data Mining valid from 2024-10-24

Version of Record valid from 2024-10-24
More Information

Article History

Received: 22 November 2023

Accepted: 21 September 2024

First Online: 24 October 2024

Declarations

:

: This research work was approved by the Institutional Animal Ethics Committee of the University of Allahabad, Prayagraj (Approval No. (IAEC/AU/2019(1)/04); (IAEC/UoA/013/2022).

: For this type of study informed consent is not required.

: For this type of study consent for publication is not required

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below